Home > Insider Trading > Filing (0001209191-14-009076)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1571498	Epizyme Inc.	EPZM	Pharmaceutical Preparations (2834)	261349956

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1180429	M Vaughn Kailian	C/O Mpm Asset Management 200 Clarendon Street, 54Th Floor Boston MA 02116	No	No	Yes	No
1356950	Paul James Scopa	C/O Mpm Asset Management 601 Gateway Blvd., Suite 350 South San Francisco CA 94080	No	No	Yes	No
1358309	Mpm Bioventures Iv Qp Lp	C/O Mpm Asset Management 200 Claredon Street, 54Th Floor Boston MA 02116	No	No	Yes	No
1358311	Mpm Bioventures Iv Gp Llc	C/O Mpm Asset Management 200 Clarendon Street, 54Th Floor Boston MA 02116	No	No	Yes	No
1358312	Mpm Bioventures Iv Llc	C/O Mpm Asset Management 200 Clarendon Street, 54Th Floor Boston MA 02116	No	No	Yes	No
1358313	Mpm Asset Management Investors Bv4 Llc	C/O Mpm Asset Management 200 Clarendon Street, 54Th Floor Boston MA 02116	No	No	Yes	No
1412336	Mpm Bioventures Iv Gmbh & Co. Beteiligungs Kg	C/O Mpm Asset Management 200 Clarendon Street, 54Th Floor Boston MA 02116	No	No	Yes	No
1473930	Todd Foley	C/O Mpm Asset Management 200 Clarendon Street, 54Th Floor Boston MA 02116	No	No	Yes	No
1577429	Mpm Bioventures Iv Strategic Fund, L.p.	C/O Mpm Asset Management 200 Clarendon Street, 54Th Floor Boston MA 02116	No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2014-02-10	466,666	$29.25	2,413,819	No	4	S	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See footnote

Footnotes

The shares were sold as follows: 377,313 by MPM BioVentures IV-QP, L.P. ("BV IV QP"), 14,536 by MPM BioVentures IV GmbH & Co. Beteiligungs KG ("BV IV KG"), 10,729 by MPM Asset Management Investors BV4 LLC ("AM BV4") and 64,088 shares by MPM BioVentures IV Strategic Fund, L.P. ("BV IV SF"). MPM BioVentures IV GP LLC and MPM BioVentures IV LLC ("BV LLC") are the direct and indirect general partners of BV IV QP, BV IV KG and BV IV SF and BV LLC is the manager of AM BV4. Ansbert Gadicke, Luke Evnin, Vaughn M. Kailian,James Paul Scopa and Todd Foley are the members of BV LLC.
The shares are held as follows: 1,951,645 by BV IV QP, 75,188 by BV IV KG, 55,495 by AM BV4 and 331,491 shares by BV IV SF. Each Reporting Person disclaims beneficial ownership of the securities except to the extent of his or its respective pecuniary interest therein.